MVIS Nasdaq Electronic Components, Nec Financials FY2016βFY2025
Microvision, Inc. had $1.2M of revenue in fiscal 2025, down 74.3% on the year before. Over five years, revenue changed β17.1% a year on average.
Last close Β· Oct 23, 2026
$1.18
3.5%Hi! I read Microvision, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β74.3%
No. Sales fell 74.3% last year.
Does it make a profit?
β7,862.7%
No. It lost money last year.
Does profit turn into cash?
β4,917.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Microvision, Inc. had $1.2M of revenue in fiscal 2025, down 74.3% on the year before. Over five years, revenue changed β17.1% a year on average. Its operating margin was β6,856.6%, down 5,035.5Β pts: of every 100 in sales, about β6,857 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Microvision, Inc. lost $95.0M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$59.4M in fiscal 2025, β4,917.1% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Microvision, Inc. has $55.6M more cash than debt.
Cash, debt and the ratios that show how comfortably Microvision, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $115M | $82.7M | $73.8M | $74.7M | $74.9M |
| Debt incl. finance leases | β | β | β | $33.0M | $19.3M |
| Debt / equity | β | β | β | 0.7x | 0.3x |
| Interest coverage | β | β869.2x | β1,110.9x | β19.2x | β11.3x |
| Current ratio | 9.6x | 8.0x | 4.2x | 1.8x | 2.7x |
| Quick ratio | 9.4x | 7.8x | 4.0x | 1.7x | 2.7x |
| Total assets | $130M | $115M | $130M | $121M | $103M |
| Total liabilities | $17.5M | $25.3M | $33.8M | $72.4M | $47.6M |
| Shareholders' equity | $113M | $89.7M | $95.8M | $48.8M | $55.5M |
| Net debt (β = net cash) | β | β | β | β$41.7M | β$55.6M |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Microvision, Inc. passes 3 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 8 | 3 / 8 | 2 / 8 | 3 / 8 | 4 / 8 | 1 / 8 | 2 / 8 | 1 / 8 | 3 / 9 |
| Accruals ratio | β8.2% | β40.1% | β17.7% | β14.0% | 14.9% | β18.2% | β12.3% | β12.9% | β22.6% | β32.3% |
| Altman Z'' | β | β | β | β | β92.19 | β5.86 | β14.23 | β17.53 | β25.26 | β31.19 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $14.8M | $9.6M | $17.6M | $8.9M | $3.1M | $2.5M | $0.7M | $7.3M | $4.7M | $1.2M |
| Gross profit | $4.4M | β$0.2M | $7.0M | $0.3M | $1.7M | $2.5M | $0.6M | $4.5M | β$2.8M | β$17.3M |
| Research and development | $12.1M | $15.1M | $24.7M | $18.7M | $9.8M | $24.1M | $30.4M | $56.7M | $49.0M | $31.7M |
| Operating income | β$16.5M | β$25.5M | β$27.2M | β$26.5M | β$13.6M | β$43.9M | β$53.9M | β$88.9M | β$85.5M | β$82.8M |
| Interest expense | β | β | β | β | β | β | $0.1M | $0.1M | $4.5M | $7.3M |
| Pretax income | β | β | β | β | β | β$43.2M | β$53.1M | β$81.7M | β$96.4M | β$95.1M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $1.1M | $0.5M | β$0.1M |
| Net income | β$16.5M | β$25.5M | β$27.3M | β$26.5M | β$13.6M | β$43.2M | β$53.1M | β$82.8M | β$96.9M | β$95.0M |
| Net income to common | β | β | β | β | β | β | β$53.1M | β$82.8M | β$96.9M | β$95.0M |
| Diluted EPS | β | β | β | β$0.24 | β$0.10 | β$0.27 | β$0.32 | β$0.45 | β$0.46 | β$0.35 |
| Diluted shares | 0.05B | 0.07B | 0.09B | 0.00B | 0.00B | 0.16B | 0.17B | 0.18B | 0.21B | 0.27B |
| Cash flow | ||||||||||
| Cash from operations | β$14.8M | β$15.5M | β$22.6M | β$24.0M | β$16.1M | β$29.4M | β$38.0M | β$67.1M | β$68.5M | β$58.7M |
| Capital expenditure | β | β | β | $0.7M | $0.4M | $2.5M | $4.4M | $1.9M | $0.4M | $0.7M |
| Free cash flow | β | β | β | β$24.8M | β$16.5M | β$31.9M | β$42.4M | β$69.0M | β$68.9M | β$59.4M |
| Depreciation and amortization | $1.1M | $1.1M | $1.8M | $1.6M | $1.0M | $1.5M | $2.2M | $7.9M | $6.9M | $5.8M |
| Stock-based compensation | $1.2M | $1.3M | $1.1M | $1.6M | $1.3M | $15.3M | $15.5M | $16.1M | $11.5M | $0.7M |
| Acquisitions | β | β | β | β | β | β | β | $11.2M | $6.3M | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $15.1M | $17.0M | $13.8M | $5.8M | $16.9M | $115M | $82.7M | $73.8M | $74.7M | $74.9M |
| Total debt | β | β | β | $0.0M | β | β | β | β | $33.0M | $19.2M |
| Finance lease liabilities | β | β | β | $0.0M | $0.1M | $0.0M | $0.0M | β | β | $0.0M |
| Current assets | $17.3M | $23.2M | $17.6M | $7.8M | $17.6M | $119M | $91.0M | $86.8M | $82.5M | $81.1M |
| Current liabilities | $7.2M | $19.1M | $18.2M | $14.5M | $10.0M | $12.5M | $11.4M | $20.5M | $46.0M | $30.1M |
| Inventory | $1.2M | $4.5M | $1.1M | $0.2M | $0.0M | $1.8M | $1.9M | $3.9M | $2.3M | $0.7M |
| Property and equipment, net | $1.5M | $3.3M | $3.0M | $1.8M | $1.9M | $3.0M | $6.8M | $9.0M | $7.1M | $4.3M |
| Intangible assets | $0.7M | $0.6M | $0.5M | $0.2M | $0.2M | $0.1M | $0.1M | $17.2M | $11.0M | $0.0M |
| Total assets | $20.1M | $29.8M | $23.0M | $11.8M | $21.0M | $130M | $115M | $130M | $121M | $103M |
| Total liabilities | $12.6M | $19.7M | $18.9M | $15.8M | $12.0M | $17.5M | $25.3M | $33.8M | $72.4M | $47.6M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β |
| Shareholders' equity | $13.9M | $10.1M | $4.1M | β$4.0M | $9.0M | $113M | $89.7M | $95.8M | $48.8M | $55.5M |
| Margins | ||||||||||
| Gross margin | 29.7% | β2.4% | 39.6% | 3.6% | 54.8% | 99.9% | 84.9% | 61.8% | β60.3% | β1,435.4% |
| Operating margin | β111.5% | β264.5% | β154.6% | β297.9% | β440.6% | β1,754.8% | β8,116.0% | β1,224.3% | β1,821.1% | β6,856.6% |
| EBITDA margin | β103.9% | β252.6% | β144.2% | β279.3% | β409.4% | β1,696.2% | β7,777.7% | β1,116.0% | β1,673.7% | β6,374.5% |
| Net margin | β111.6% | β264.5% | β154.8% | β298.0% | β441.2% | β1,728.0% | β7,995.6% | β1,141.2% | β2,063.8% | β7,862.7% |
| FCF margin | β | β | β | β279.0% | β533.2% | β1,275.9% | β6,382.2% | β950.9% | β1,467.5% | β4,917.1% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | β | β953.6% | β |
| Return on capital employed | β128.0% | β238.3% | β561.8% | 1,010.4% | β124.0% | β37.3% | β52.0% | β81.4% | β113.7% | β113.5% |
| Return on equity | β118.2% | β212.2% | β383.7% | β37,832.9% | β541.9% | β71.0% | β52.4% | β89.3% | β134.1% | β182.1% |
| Return on assets | β81.9% | β102.2% | β103.2% | β151.9% | β83.0% | β57.1% | β43.3% | β67.7% | β77.3% | β84.7% |
| Return on tangible equity | β124.6% | β268.7% | β750.5% | β | β154.1% | β38.4% | β59.2% | β105.4% | β256.4% | β171.1% |
| Growth | ||||||||||
| Revenue growth | β | β34.7% | 82.8% | β49.5% | β65.2% | β19.1% | β73.4% | 993.2% | β35.3% | β74.3% |
| Share count change | β | 40.1% | 19.5% | β99.9% | 25.6% | 114,822.7% | 3.3% | 10.1% | 14.6% | 30.4% |
| Financial health | ||||||||||
| Debt / equity | β | β | β | β | β | β | β | β | 0.7x | 0.3x |
| Interest coverage | β | β | β | β | β | β | β869.2x | β1,110.9x | β19.2x | β11.3x |
| Current ratio | 2.4x | 1.2x | 1.0x | 0.5x | 1.8x | 9.6x | 8.0x | 4.2x | 1.8x | 2.7x |
| Quick ratio | 2.2x | 1.0x | 0.9x | 0.5x | 1.8x | 9.4x | 7.8x | 4.0x | 1.7x | 2.7x |
| Capital allocation | ||||||||||
| Capex / revenue | β | β | β | 8.4% | 13.0% | 99.7% | 656.5% | 26.7% | 8.0% | 56.2% |
| Stock comp / revenue | 8.3% | 13.4% | 6.0% | 18.2% | 42.0% | 611.4% | 2,328.5% | 222.4% | 245.6% | 58.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 1.0 | 3.0 | 2.0 | 3.0 | 4.0 | 1.0 | 2.0 | 1.0 | 3.0 |
| Altman Z'' | β | β | β | β | β92.2 | β5.9 | β14.2 | β17.5 | β25.3 | β31.2 |
| Accruals ratio | β8.2% | β40.1% | β17.7% | β14.0% | 14.9% | β18.2% | β12.3% | β12.9% | β22.6% | β32.3% |
Source: SEC EDGAR XBRL filings (CIK 0000065770). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
